Updated Guidelines Advise on Outpatient Parenteral Antimicrobial Therapy – Drug for nerve pain boosts high for opioid abusers.

3Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Updated Guidelines Advise on Outpatient Parenteral Antimicrobial Therapy – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

An infectious diseases (ID) specialist should be consulted before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital, suggest updated guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases. Once they begin receiving outpatient parenteral antimicrobial therapy (OPAT), patients should be monitored regularly, according to the guidelines.

Since previous guidelines were published in 2004, large studies have concluded that there is no difference in the number of adverse events related to OPAT compared to hospital-administered IV antimicrobial therapy. Additionally, recently-published research underscores the value of review by an ID physician, nurse, or pharmacist before starting OPAT, noting that it is associated with a lower risk of hospital readmission. In many cases a specialist will recommend an oral instead of an IV antimicrobial, and one study concluded that an ID specialist-led stewardship program reduced pediatric OPAT orders by 24%, without increasing readmissions.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.